Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$207.04
6.012.99%
al cierre: -
$207.65
0.610.29%
After hour: 7:59 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
NVIDIA Corp ha un obiettivo di prezzo di consenso pari a $220.56, stabilito in base alle ultime valutazioni degli analisti di 36. Le ultime 3 valutazioni degli analisti sono state rilasciate da DA Davidson, UBS y Cantor Fitzgerald il octubre 29, 2025. Con un obiettivo di prezzo medio di $261.67 tra le DA Davidson, UBS y Cantor Fitzgerald, c'è un implicito 26.01% upside per NVIDIA Corp da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
DA Davidson
UBS
Cantor Fitzgerald
B of A Securities
HSBC
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para NVIDIA
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/29/2025 | 20.39% | DA Davidson | $210 → $250 | Maintains | Buy | |||
10/29/2025 | 13.17% | UBS | $205 → $235 | Maintains | Buy | |||
10/29/2025 | 44.47% | Cantor Fitzgerald | $300 → $300 | Reiterates | Overweight → Overweight | |||
10/29/2025 | 32.43% | B of A Securities | $235 → $275 | Maintains | Buy | |||
10/15/2025 | 54.11% | HSBC | $200 → $320 | Upgrade | Hold → Buy | |||
10/13/2025 | 8.36% | Mizuho | $205 → $225 | Maintains | Outperform | |||
10/09/2025 | 44.47% | Cantor Fitzgerald | $240 → $300 | Maintains | Overweight | |||
10/03/2025 | 15.58% | Cantor Fitzgerald | $240 → $240 | Reiterates | Overweight → Overweight | |||
09/30/2025 | 20.39% | Keybanc | $230 → $250 | Maintains | Overweight | |||
09/30/2025 | 1.13% | Citigroup | $200 → $210 | Maintains | Buy | |||
09/29/2025 | 5.95% | Jefferies | — | $205 → $220 | Maintains | Buy | ||
09/25/2025 | 15.58% | Barclays | $200 → $240 | Maintains | Overweight | |||
09/23/2025 | 1.13% | DA Davidson | $210 → $210 | Maintains | Buy | |||
09/23/2025 | 8.36% | Evercore ISI Group | $214 → $225 | Maintains | Outperform | |||
09/23/2025 | 3.54% | Rosenblatt | $215 → $215 | Maintains | Buy | |||
09/11/2025 | 1.13% | DA Davidson | $195 → $210 | Upgrade | Neutral → Buy | |||
09/08/2025 | -3.68% | Citigroup | $210 → $200 | Maintains | Buy | |||
09/04/2025 | 3.54% | JP Morgan | $215 → $215 | Maintains | Overweight | |||
08/28/2025 | 1.13% | Citigroup | $190 → $210 | Maintains | Buy | |||
08/28/2025 | 3.54% | JP Morgan | $170 → $215 | Maintains | Overweight | |||
08/28/2025 | -6.09% | DA Davidson | $135 → $195 | Maintains | Neutral | |||
08/28/2025 | -3.68% | Goldman Sachs | $200 → $200 | Reiterates | Buy → Buy | |||
08/28/2025 | 17.99% | Craig-Hallum | $195 → $245 | Maintains | Buy | |||
08/28/2025 | 8.36% | Oppenheimer | $200 → $225 | Maintains | Outperform | |||
08/28/2025 | 1.13% | Morgan Stanley | $206 → $210 | Maintains | Overweight | |||
08/28/2025 | 13.17% | B of A Securities | $220 → $235 | Maintains | Buy | |||
08/28/2025 | 1.13% | Wedbush | $210 → $210 | Reiterates | Outperform → Outperform | |||
08/28/2025 | 9.8% | Truist Securities | $210 → $228 | Maintains | Buy | |||
08/28/2025 | 15.58% | Cantor Fitzgerald | $240 → $240 | Reiterates | Overweight → Overweight | |||
08/28/2025 | 10.76% | Keybanc | $215 → $230 | Maintains | Overweight | |||
08/28/2025 | 8.36% | Bernstein | $185 → $225 | Maintains | Outperform | |||
08/28/2025 | 3.54% | Rosenblatt | $200 → $215 | Maintains | Buy | |||
08/28/2025 | 5.95% | Benchmark | $190 → $220 | Maintains | Buy | |||
08/28/2025 | -3.68% | Needham | $200 → $200 | Reiterates | Buy → Buy | |||
08/25/2025 | 2.09% | Stifel | $202 → $212 | Maintains | Buy | |||
08/25/2025 | 8.36% | Baird | $195 → $225 | Maintains | Outperform | |||
08/22/2025 | 3.06% | Evercore ISI Group | $190 → $214 | Maintains | Outperform | |||
08/21/2025 | -1.28% | UBS | $175 → $205 | Maintains | Buy | |||
08/21/2025 | 1.13% | Wedbush | $175 → $210 | Maintains | Outperform | |||
08/20/2025 | 3.54% | Keybanc | $190 → $215 | Maintains | Overweight | |||
08/19/2025 | 13.17% | TD Cowen | $140 → $235 | Maintains | Buy | |||
08/18/2025 | 15.58% | Cantor Fitzgerald | $200 → $240 | Maintains | Overweight | |||
08/18/2025 | -0.79% | Morgan Stanley | $200 → $206 | Maintains | Overweight | |||
08/14/2025 | -1.28% | Mizuho | $192 → $205 | Maintains | Outperform | |||
08/13/2025 | 8.36% | Piper Sandler | $180 → $225 | Maintains | Overweight | |||
08/11/2025 | 5.95% | Wells Fargo | $185 → $220 | Maintains | Overweight | |||
08/07/2025 | -3.68% | Goldman Sachs | $185 → $200 | Maintains | Buy | |||
08/04/2025 | 5.95% | B of A Securities | $220 → $220 | Reiterates | Buy → Buy | |||
07/30/2025 | -3.68% | Morgan Stanley | $170 → $200 | Maintains | Overweight | |||
07/16/2025 | -7.54% | Mizuho | $185 → $192 | Maintains | Outperform | |||
07/16/2025 | -3.68% | Needham | $160 → $200 | Maintains | Buy | |||
07/15/2025 | 5.95% | B of A Securities | $180 → $220 | Maintains | Buy | |||
07/15/2025 | -6.09% | DZ Bank | $160 → $195 | Maintains | Buy | |||
07/15/2025 | 13.17% | Melius Research | $205 → $235 | Maintains | Buy | |||
07/15/2025 | -3.68% | Oppenheimer | $175 → $200 | Maintains | Outperform | |||
07/10/2025 | -10.91% | Goldman Sachs | → $185 | Initiates | → Buy | |||
07/07/2025 | -8.5% | Citigroup | $180 → $190 | Maintains | Buy | |||
07/03/2025 | -10.91% | Mizuho | $170 → $185 | Maintains | Outperform | |||
06/25/2025 | 20.39% | Loop Capital | $175 → $250 | Maintains | Buy | |||
06/17/2025 | -3.68% | Barclays | $170 → $200 | Maintains | Overweight | |||
06/16/2025 | -15.72% | Oppenheimer | $175 → $175 | Reiterates | Outperform → Outperform | |||
05/29/2025 | -13.32% | B of A Securities | $160 → $180 | Maintains | Buy | |||
05/29/2025 | 1.13% | Truist Securities | $205 → $210 | Maintains | Buy | |||
05/29/2025 | -20.54% | Raymond James | $150 → $165 | Maintains | Strong Buy | |||
05/29/2025 | -13.32% | Piper Sandler | $150 → $180 | Maintains | Overweight | |||
05/29/2025 | -18.13% | Mizuho | $168 → $170 | Maintains | Outperform | |||
05/29/2025 | -13.32% | Citigroup | $150 → $180 | Maintains | Buy | |||
05/29/2025 | -18.13% | Morgan Stanley | $160 → $170 | Maintains | Overweight | |||
05/29/2025 | -18.13% | Barclays | $155 → $170 | Maintains | Overweight | |||
05/29/2025 | -34.99% | DA Davidson | $120 → $135 | Maintains | Neutral | |||
05/29/2025 | -3.68% | Rosenblatt | $178 → $200 | Maintains | Buy | |||
05/29/2025 | -8.5% | Benchmark | $190 → $190 | Reiterates | Buy → Buy | |||
05/29/2025 | -22.95% | Needham | $160 → $160 | Reiterates | Buy → Buy | |||
05/22/2025 | -15.72% | Wedbush | $175 → $175 | Reiterates | Outperform → Outperform | |||
05/14/2025 | -22.95% | B of A Securities | $150 → $160 | Maintains | Buy | |||
05/12/2025 | -15.72% | UBS | $180 → $175 | Maintains | Buy | |||
04/30/2025 | -51.84% | Seaport Global | → $100 | Initiates | → Sell | |||
04/25/2025 | -22.95% | Morgan Stanley | $162 → $160 | Maintains | Overweight | |||
04/23/2025 | -14.28% | Rosenblatt | $200 → $178 | Maintains | Buy | |||
04/22/2025 | -25.36% | Barclays | $175 → $155 | Maintains | Overweight | |||
04/17/2025 | -13.32% | UBS | $185 → $180 | Maintains | Buy | |||
04/16/2025 | -8.5% | Evercore ISI Group | $190 → $190 | Reiterates | Outperform → Outperform | |||
04/16/2025 | -3.68% | Rosenblatt | $220 → $200 | Maintains | Buy | |||
04/16/2025 | -42.21% | DA Davidson | $120 → $120 | Maintains | Neutral | |||
04/16/2025 | -27.76% | Raymond James | $170 → $150 | Maintains | Strong Buy | |||
04/16/2025 | -3.68% | Cantor Fitzgerald | $200 → $200 | Reiterates | Overweight → Overweight | |||
04/16/2025 | -27.76% | Piper Sandler | $175 → $150 | Maintains | Overweight | |||
04/16/2025 | -15.72% | Wedbush | $175 → $175 | Reiterates | Outperform → Outperform | |||
04/16/2025 | -22.95% | B of A Securities | $200 → $160 | Maintains | Buy | |||
04/14/2025 | -42.21% | DA Davidson | $125 → $120 | Maintains | Neutral | |||
04/11/2025 | -27.76% | Citigroup | $163 → $150 | Maintains | Buy | |||
04/09/2025 | -32.58% | TD Cowen | $175 → $140 | Maintains | Buy | |||
03/20/2025 | -39.8% | DA Davidson | $135 → $125 | Maintains | Neutral | |||
03/20/2025 | -8.5% | Benchmark | $190 → $190 | Reiterates | Buy → Buy | |||
03/19/2025 | -13.32% | Susquehanna | $180 → $180 | Maintains | Positive | |||
03/19/2025 | -3.68% | Cantor Fitzgerald | $200 → $200 | Reiterates | Overweight → Overweight | |||
03/19/2025 | — | Keybanc | — | Reiterates | Overweight → Overweight | |||
03/19/2025 | -3.68% | B of A Securities | $200 → $200 | Reiterates | Buy → Buy | |||
03/19/2025 | -22.95% | Needham | $160 → $160 | Reiterates | Buy → Buy | |||
03/19/2025 | 5.95% | Rosenblatt | $220 → $220 | Maintains | Buy |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de NVIDIA (NVDA)?
El último precio objetivo de NVIDIA (NASDAQ:NVDA) fue comunicado por DA Davidson el octubre 29, 2025. La firma de analistas fijó un precio objetivo para $250.00 que espera NVDA a rise dentro de 12 meses (un posible 20.39% upside). 100 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre NVIDIA (NVDA)?
La última calificación de analistas para NVIDIA (NASDAQ:NVDA) fue proporcionada por DA Davidson, y NVIDIA mantuvo su buy calificación.
¿Cuándo se produjo la última revisión al alza de NVIDIA (NVDA)?
La última revisión al alza de NVIDIA Corp se produjo en octubre 15, 2025, cuando HSBC elevó su precio objetivo a $320. HSBC anteriormente tenía a hold para NVIDIA Corp.
¿Cuándo fue la última revisión a la baja de NVIDIA (NVDA)?
No hay una última revisión a la baja para NVIDIA.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para NVIDIA (NVDA)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de NVIDIA, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de NVIDIA se registró el octubre 29, 2025, por lo que la próxima calificación estará disponible en torno al octubre 29, 2026.
¿Es correcta la calificación de los analistas sobre NVIDIA (NVDA)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de NVIDIA (NVDA) fue un mantuvo con un precio objetivo de $210.00 a $250.00. El precio actual al que cotiza NVIDIA (NVDA) es de $207.65, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.